Cancer Risk and Prevention Research (Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research)

Overview:

• Participating Organization(s): National Institutes of Health (NIH), National Cancer Institute (NCI)
• Components of Participating Organizations:
  • National Cancer Institute (NCI)
  • Innovative Molecular Analysis Technologies (IMAT) program
• Funding Opportunity Number: RFA-CA-25-006
• Companion Funding Opportunity: Clinical Trial Optional
• Funding Opportunity Purpose:
  • To encourage revision applications from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or device developed through support from the NCI IMAT program.
• Award(s): Cooperative Agreements
• Opportunity Goal(s):
  • Identify cancer risks and risk reduction strategies.
  • Identify factors that cause cancer in humans.
  • Discover and develop mechanisms for cancer prevention and preventive interventions in humans.
  • Develop the means to cure as many cancer patients as possible and to control the disease in those patients who are not cured.
  • Provide fundamental information on the cause and nature of cancer in people.
  • Reduce cancer risk, incidence, morbidity, and mortality and enhance quality of life in cancer survivors.
• Deadline(s): March 04, 2025 (Letter of Intent), April 04, 2025 (Application Due Date)
• Open Date(s): December 31, 2024
• Anticipated Funding Amount: \$700,000 cost shared / funded
• Estimated Number of Awards: 3
• Estimated Award Amount Range: \$0 - \$150,000 direct costs per year
• Estimated Project Duration: 2 to 5 years
• Contact(s):

• Application Submission Contacts:
• eRA Service Desk - https://www.era.nih.gov/need-help (preferred method of contact), 301-402-7469 or 866-504-9552 (toll free)
• General Grants Information - grantsinfo.gov (preferred method of contact), 301-480-7075
• Grants.gov Customer Support - Contact Center Telephone: 800-518-4726, support.gov
• Scientific/Research Contact(s):
• Kelly Crotty, PhD, National Cancer Institute (NCI), [email protected], 240-255-0917
• Referral Officer Contact(s):
• National Cancer Institute (NCI), [email protected], 240-276-6390
• Financial/Grants Management Contact(s):
• Sean Hine, National Cancer Institute (NCI), [email protected], 240-276-6291

Additional Information:

• Program Website: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-006.html
• Agency Contact: Referral Officer, National Cancer Institute (NCI), [email protected], 240-276-6390

Full Announcement: